-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The prognosis of high-grade glioma (HGG) and diffuse intrinsic glioma (DIPG) is still not optimistic.
Child Vascular Diagnosis
From September 2009 to August 2015, 38 children with DIPG and HGG (20 in the DIPG group and 18 in the HGG group) aged 3-21 years were enrolled in the study to receive radiotherapy and VPA at a dose of 15 mg/kg/day.
The results showed that during radiotherapy and VPA, adverse reactions of grade ≥3 that required stopping or modifying the VPA dose included grade 3 thrombocytopenia (1), grade 3 weight gain (1), and grade 3 pancreatitis (1).
thrombus
The median event-free survival (EFS) and overall survival (OS) in the DIPG group were 7.
In summary, the results of this study show that radiotherapy combined with VPA and bevacizumab is well tolerated, but it does not seem to improve EFS or OS in children with DIPG or HGG.
Original source:
Jack Meng-Fen Su, et al.
ncbi.
Leave a message here